Life Sciences Adicet Bio Reports Positive Clinical Update from ADI-001 Phase 1 Trial in Relapsed/Refractory… AIT News Desk May 27, 2022 Adicet Bio, Inc., a clinical stage biotechnology company discovering and developing first-in-class allogeneic gamma delta chimeric antigen receptor…
Healthcare Management Bristol Myers Squibb Data at ASCO and EHA 2022 Highlight Progress in Transforming Treatment for… AIT News Desk May 26, 2022 Bristol Myers Squibb announced the presentation of scientific research across cancers and blood disorders at the 2022 American Society of Clinical…